About Sudo Bio
Sudo Biosciences develops first- and best-in-class medicines for serious neurological and immunological conditions like multiple sclerosis (MS) and other immune-mediated inflammatory conditions.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
sudobio.com
Domain Registered Date
Mar 25, 2020
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $37,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
sudobio.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Sudo Bio.
Funding History
Series-A
· Sep 28, 2022
$37,000,000 fundraisingfox.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026